8 | Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022
-
02/2002 |
5 | Glucose (Dextrose)FDA LinkGeneric
01/2022
-
04/2008 |
5 | Blood Glucose (Blood Sugar)IBA
01/2018
-
03/2003 |
4 | Exenatide (Byetta)FDA Link
01/2021
-
03/2010 |
4 | Glucagon-Like Peptide-1 ReceptorIBA
01/2020
-
11/2011 |
3 | Glucagon (Glukagon)FDA Link
01/2022
-
11/2003 |
3 | erythromycin propionate-N-acetylcysteinateIBA
10/2018
-
03/2003 |
3 | Hormones (Hormone)IBA
11/2003
-
02/2002 |
2 | Cholecystokinin (Pancreozymin)IBA
03/2022
-
01/2020 |
2 | GastrinsIBA
03/2022
-
01/2020 |
2 | Insulin (Novolin)FDA Link
01/2022
-
02/2002 |
2 | Peptides (Polypeptides)IBA
01/2021
-
01/2018 |
2 | Glucagon-Like Peptide-1 Receptor AgonistsIBA
11/2011
-
11/2003 |
2 | Adenosine Triphosphate (ATP)IBA
03/2010
-
04/2008 |
1 | Chelating AgentsIBA
03/2022 |
1 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
03/2022 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2022 |
1 | 3-(2,4-dimethoxybenzylidene)anabaseineIBA
01/2022 |
1 | Sitagliptin Phosphate (Januvia)FDA Link
01/2022 |
1 | Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
12/2020 |
1 | carboxyaminoimidazole ribotide (CAIR)IBA
12/2020 |
1 | Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2018 |
1 | 2- (2- (4- bromophenyl)- 6- methylpyrimidin- 4- yl)aminoethanolIBA
06/2016 |
1 | Proglucagon (Glucagon Precursors)IBA
06/2016 |
1 | Pharmaceutical PreparationsIBA
06/2016 |
1 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2014 |
1 | LiraglutideFDA Link
11/2011 |
1 | Fura-2 (Fura 2)IBA
09/2006 |
1 | Indicators and Reagents (Reagents)IBA
09/2006 |